Failure to maintain adequate insulin sensitivity and action, commonly referred to as insulin resistance, is a hallmark of various metabolic diseases in humans, such as metabolic syndrome1 (MetS), type II diabetes2 (T2D) and non-alcoholic fatty liver disease1. This evidence concerns the gene INS and metabolic syndrome.